Moderate Dysplasia of Vulva
1 clinical trials · Condition
◉ Watch Moderate Dysplasia of Vulva
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
Track Moderate Dysplasia of Vulva automatically
Every clearance here is in the API, with alerts when new ones post.